Skip to main content

I have been into the research industry for the past 5 years. I have a fascination and profound information about the research industry. I have a stretch of experience serving as a Research Analyst. My take on the impact of digital technologies across the science, technology and business domains gives his writing a fresh and modern outlook.

Polymerase Chain Reaction Consumables Market to Register Substantial Expansion by 2024

5 min read

Transparency Market Research (TMR) has published a new report titled, Polymerase Chain Reaction (PCR) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” According to the report, the global PCR market is projected to reach over US$ 7.0 Bn by 2026 expanding at a considerable CAGR from 2018 to 2026. North America is expected to dominate the global PCR market during the forecast period, due to high adoption of technologically advanced molecular diagnostic products, growing incidence of infectious diseases, rising prevalence of various types of cancer, growing trend of self-diagnosis of diseases, and affordability of high-cost testing processes for people in the region.

Reagents Segment to Dominate the Global PCR Market

The report offers detailed segmentation of the global PCR market based on product and end-user. In terms of product, the market has been segmented into instruments, reagents, and consumables. The reagents segment held the leading market share in the year 2017 and is expected to expand at the highest CAGR during the forecast period. This is attributable to high consumption of reagents for the PCR technique. Introduction of advanced reagents specific to the type of test is expected to boost the global demand for PCR reagents in the near future. PCR reagents include template DNA, PCR primers and probes, dNTPs, PCR buffers, enzymes, and master mixes. PCR consumables mostly include PCR tubes, plates, and other accessories required to conduct PCR reactions. The instruments segment has been sub-categorized into standard PCR systems, RT PCR systems, and digital PCR systems. Among these, the digital PCR systems sub-segment is expected to witness growth at a significantly rapid pace during the forecast period. This is attributable to advantages of digital PCR systems such as precision, sensitivity, accuracy, reproducibility, direct quantification and multiplexing, and speed of the analysis.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=830

Pharmaceutical & Biotechnology Industry Segment Held a Major Share of the Global PCR Market in 2017

The PCR technique has been found to be useful in pharmaceutical and biotechnology research activities as well as microbial quality testing. The technique is also applied in genetic engineering. Genetic engineering is the key driver for the global PCR market. It is used to identify genes related to certain phenotypes including genetic disorders. Regular testing of the microbial load of raw materials and finished products is an important process in the pharmaceutical & biotechnology industry. Sophisticated analytical methods such as polymerase chain reaction (PCR) have been widely applied for quality control analysis in the pharmaceutical sector.

Market in Asia Pacific to Expand at a High CAGR

Molecular diagnosis has revolutionized the modern diagnosis technology. PCR has become a method of choice in early and accurate detection of diseases. Expansion by leading manufacturers of PCR products in the Asia Pacific region by strengthening of the distribution network and new product launches in developing countries of Asia Pacific are key factors likely to drive the PCR market in the region during the forecast period. Moreover, rise in the incidence of cancer and infectious diseases has resulted in increase in the demand for use of the PCR technique in clinical diagnosis of these diseases in Asia Pacific. For instance, according to the Korea Central Cancer Registry published in 2016, there were 217,057 cancer cases in South Korea in 2014. Moreover, in 2016, the WHO estimated that the Asia Pacific region has the second-highest number (i.e. 5.1 million) of people living with HIV across the world. Thus, Asia Pacific is expected to be the most lucrative market for PCR by 2026.

Request for Analysis of COVID19 Impact on Polymerase Chain Reaction Consumables Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=830

Competition Landscape

Major players operating in the global PCR market are Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies. Key players are expanding their product portfolio through mergers and acquisitions and partnerships and collaborations with leading pharmaceutical and biotechnology companies and by offering technologically advanced products.

Purchase Polymerase Chain Reaction Consumables Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=830<ype=S

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

 

Surgical Staplers Market to Set Phenomenal Growth by 2026

4 min read

The global surgical staplers market is anticipated in a report by Transparency Market Research (TMR) to witness the highly consolidated nature of its vendor landscape. This could be because of the presence of a handful of large-scale private and public medical devices vendors. A few companies based in developed economies are expected to show their dominance over the market. Close to an 80.0% share of the market is held by Johnson & Johnson Services, Inc. and Covidien Plc. However, other prominent names of the market, viz. Grena Ltd., Victor Medical Instruments Co., Ltd., and Purple Surgical International Ltd. could look too improve their presence in the industry.

TMR predicts the global surgical staplers market to rise at a 7.5% CAGR between 2018 and 2026 to be valued at a US$4.0 bn by the final forecast year. In 2017, the market gained a valuation of US$2.0 bn. Disposable surgical staplers could take the lead in the market among other products while securing an expected share of 78.0% by the end of 2026. Regionally, North America is foreseen to achieve a larger share of the market, considering its US$0.9 bn revenue earned in 2018.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45381

Wide Use of Surgical Staplers in Minimally Invasive Surgeries to Swell Demand

Growing use of surgical staplers in minimally invasive procedures such as flexible endoscopic procedures, general surgeries, laparoscopic procedures, cosmetology procedures, and colorectal surgeries is foretold to push the growth of the market in the near future. Millions of such procedures were conducted in the U.S. in the recent past, according to Ethicon U.S., LLC. Interestingly, these procedures are going to increase in the coming years, as per the findings of the company. The demand for minimally invasive procedures could increase due to the rising awareness about their various advantages, including faster recovery, less pain, reduced risk of infection, and minimal complications.

Functional Failure of Surgical Staplers during Surgeries to Arrest Market Growth

Availability of alternatives to surgical staplers is envisioned to hamper the growth of the market. Another factor that could restrict market growth could be the functional failure of surgical staplers during surgeries. Issues associated with the functionality of surgical staplers such as separated suture lines, misfiring or firing failure, and failure in the formation of staples are projected to impede the growth in demand. Thousands of adverse events due to the use of surgical staplers have been reported in the last five years, according to the FDA.

Request for Analysis of COVID19 Impact on Surgical Staplers Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=45381

Despite of all these negative factors affecting the rise of the global surgical staplers market, there could be favorable prospects birthing on the back of the growing trend of robotic or computer-assisted minimally invasive surgery. On the other hand, high adoption of such surgeries in medical centers and other facilities is prognosticated to create a whole lot of opportunities in the market.

The information presented in this review is based on a TMR report, titled “Surgical Staplers Market (Product - Disposable and Reusable; Application - General Surgery, Colorectal, Gynecology, and Urology; Technology - Manual Devices and Powered Devices; Ergonomics - Curved and Linear; End Use - Hospitals and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.”

Purchase Surgical Staplers Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=45381<ype=S

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

Website: https://www.transparencymarketresearch.com

Helicobacter Pylori Non-invasive Testing Market Size, Share, Growth Trends, and Forecast Analysis

6 min read

The global helicobacter pylori (H. pylori) non-invasive testing market was valued at approximately US$ 518.0 Mn in 2017 and is projected to register a compounded annual growth rate (CAGR) of over 3.99% from 2018 to 2026, according to a new report titled, “Helicobacter Pylori (H. pylori) Non-invasive Testing Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”, published by Transparency Market Research (TMR) . The report suggests that factors, such as, rise in the adoption of non-invasive testing for diagnosis of H. pylori, lack of endoscopic facilities, and upcoming technologically-advanced tests from global market players for non-invasive helicobacter pylori testing in the next few years (2018-2026) are likely to boost the demand for global helicobacter pylori (H. pylori) non-invasive tests. High awareness and diagnosis rate of H. pylori infection in North America and high prevalence of the disease in East-European countries are likely to generate a significant share for the market in North America and Europe from 2018 to 2026.

Rise in adoption of non-invasive tests for H. pylori diagnosis globally to fuel the market

There has been a growing preference for non-invasive tests globally for H. pylori infection testing among patients as well as health care providers, owing to quick turnaround time for test results, higher patient compliance, and reduced discomfort usually associated with invasive tests. At the same time, these tests are high in accuracy and specificity to aid the correct diagnosis of the H. pylori infection. Non-invasive tests are also cost-effective compared to invasive endoscopic options.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45312

Serology test segment to lose market share

Among non-invasive tests, serology test is commonly prescribed by health care practitioners for H. pylori owing to the relatively lower cost and ease of conducting of the test. However, the serology test segment is expected to lose its market share during the forecast period. Regional agencies such as American Gastroenterology Association (AGA) and National Health Services (NHS) have updated their guidelines to prevent the use of serology testing for detection of H. pylori due to high incidence rate of false positives, lower specificity as compared to other non-invasive testing methods, and inability to test for eradication of the H. pylori infection in a patient associated with the test. The serology test segment is estimated to hold a market share of 30.3% by the end of 2018, while its market share is anticipated to drop to 13.7% by the end of 2026.

Laboratory-based tests segment to witness significant growth

Among test methods, the laboratory-based tests segment of the global helicobacter pylori (h. pylori) non-invasive testing market is estimated to witness a significant growth during the forecast period. The segment is likely to expand at a CAGR of 3.73% between 2018 and 2026. Growth of the segment can be ascribed to the fact that a majority of these tests are performed in laboratory settings, based on laboratory methods, conducted by trained professionals in a controlled environment. Laboratories are capable of conducting high volume of tests per day and providing the results in a few hours or a few days (1 to 2 days). According to WHO, in Asia Pacific, an estimated 70% of health decisions are based on laboratory results, as laboratory-based tests provide essential support and facilitate appropriate medical intervention.

Request for Analysis of COVID19 Impact on Helicobacter Pylori Non-invasive Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=45312

Diagnostic laboratories to be highly promising among end-users

Among end users, the diagnostic laboratories segment is expected to hold the leading i.e. 47.5% share of the market by 2026. This can be attributed to the large number of H. pylori non-invasive tests performed by standalone and hospital-based diagnostic laboratories. Moreover, presence of major standalone laboratories, testing a large number of patient, and high adoption of new tests and instruments by diagnostic laboratories for diagnosis of H. pylori, is expected to fuel the growth of the diagnostic laboratories segment through 2026.

Asia Pacific to witness significant growth and create high incremental opportunity

The helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific is estimated to expand at a significant CAGR of 4.52% during the forecast period. The market in the region is likely to be driven by the high prevalence of H. pylori in rural India, (80% or even more), where a vast population is living under poverty and gastric cancer burden, linked to H. pylori bacteria, is relatively high. North America is expected to hold the leading market share of 31.1% by 2026, due to rising incidence of gastric adenocarcinoma, peptic ulcers, and other diseases which are strongly associated with H. pylori infection. This has prompted national and regional health care agencies in the U.S. to actively promote non-invasive diagnostic tests for chronic as well as acute dyspeptic patients, with an aim to eradicate H. pylori infection from among the prevalent population. The helicobacter pylori (H. pylori) non-invasive testing market in North America is likely to register a CAGR of 3.62% during the forecast period.

Key players to continue leading global helicobacter pylori (H. pylori) non-invasive testing market

Prominent players operating in the global helicobacter pylori (h. pylori) non-invasive testing market are DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. These key players are expected to maintain their key positions during the forecast period.

Purchase Helicobacter Pylori Non-invasive Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=45312<ype=S

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:
https://www.transparencymarketresearch.com/

 

 

Corporate Wellness Market Outlook for Major Applications/end Users, Consumption, Share and Growth Rate 2027

5 min read

Employee welfare is gaining center-stage as across countries, governments demand it and companies witness benefits accrue on account of better employee well-being. Not only do such programs and initiatives help improve emotional and physical health of a large segment of population but also they help in improving work performance. As per Transparency Market Research, “The global corporate wellness market is on an upward curve and a number of interesting growth opportunities are anticipated to emerge over the forecast period particularly for large MNCs and corporate houses that are already involved in such initiatives. It is expected that areas such as healthcare, individual needs, and insurance will be hotbeds.”

One of the most significant areas that are expected to drive the market on to a higher growth trajectory over the forecast period is health risk assessment. It holds a special place in the overall growth story owing to being one of the most needed elements in terms of well-being. Besides, it allows for better work output if the employees are in the best of their health. A number of schemes that are seeing an increase in implementation are smoking cessation, nutritional advice, fitness drills, health screening, and weight management. Governments across the globe have been quite emphatic in their push towards improvement in health and wellness. They have also pushed for better safety and hygiene of employees.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4743

Transparency Market Research states that the over the forecast period global corporate wellness market would grow by a rate of 8.8%, compounded annually over the period 2018 to 2026. A number of companies are working towards improving their performance index by improving work and efforts directed towards such corporate wellness programs, driving the market forward by a substantial value. It is also worth noting that the North America would hold a prominent place in the regional charts with a sizeable revenue accounted for by the region. 

Asia Pacific Region to Chart Notable Growth in the Global Corporate Wellness Market over the Forecast Period

A number of companies in the global corporate wellness market are now eyeing the Asia Pacific (APAC) region owing to factors such as anticipation regarding higher growth rate, leading to a number of untapped growth opportunities. In order to understand what is driving the region o remarkable growth, it is significant to understand that a lot of Foreign Direct Investment is pouring in the region. Intellectual resources are also making their way in the market. Thus one notes an increase in training modules, welfare schemes and healthcare guidelines. Besides, there is push from employees and the government to put such safeguards in place.

It is also worth noting here that a sizeable share of revenue will be accounted for by regions such as North America and Europe, which are developed, and implemented such schemes way back, and are now ready to capitalize upon that move. Presence of strong players in the two regions is also a significant factor, propelling growth in the market.

Request for Analysis of COVID19 Impact on Corporate Wellness Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4743

Fragmented and Competitive – Vendor Landscape of Global Corporate Wellness Explained

The global corporate wellness market is fragmented and leading players include ComPsych Corporation, Central Corporate Wellness, Optum, Inc., Truworth Wellness, SOL Wellness, JLT Australia (Recovre Group), Sodexo, and ConneXions Asia.Market players are contributing positively to the growth of global corporate wellness market by their proactive and creative measures taken up at regular intervals. To consolidate market position and penetrate new markets, players often deploy strategies such as alliances – mergers and acquisitions, and partnerships and collaborations. As per Transparency Market Research, “These allow players to combine know-how, resources, and technology improvement. Besides, a firm grasp on the market can be achieved via strategic alliances based on mutual synergies.

Purchase Corporate Wellness Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=4743<ype=S

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. 

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Hospital Asset Management Market Trends, Current Demand, and Business Opportunities

4 min read

Transparency Market Research (TMR) has published a new report titled, “Hospital Asset Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global hospital asset management market was valued at US$ 5.0 Bn in 2017 and is projected to expand at a CAGR of 12.0% from 2018 to 2026. Improvement and optimization of workflow, safety, and productivity; reduction in inventory, and higher return on investment are anticipated to boost the growth of the global hospital asset management market during the forecast period. Developed regions having better health care IT infrastructure are likely to account for major market share in terms of revenue in the next few years. Major market players are involved in continuous technological advancements through focused research and development activities, which is resulting in development of cost-effective solutions. Some of the prominent players are likely to expand their geographical presence through partnership agreements in the high growth potential developing markets during the forecast period.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1926

Real-time Location Systems Segment to Account for Over Half the Market Share

The report offers detailed segmentation of the global hospital asset management market based on product and application. In terms of product, the real-time location systems (RTLS) segment is poised to account for major share of the global market in terms of revenue between 2018 and 2026. Factors attributed to high market share of the segment include strong brand presence of key players offering proprietary product technologies and technical advantages such as the ability of outdoor asset tracking, information encryption service, and tamper evident sensor, among others.

Instrument Management Segment to Register Above Average Growth Rate

In terms of application, the global hospital asset management market has been categorized into patient management, staff management, instrument management, and supply chain management. The instrument management segment is anticipated to expand at a moderate growth rate during the forecast period. Intense competition between established companies as well as new entrants is likely to result in affordable asset tags during the forecast period. This in turn is expected to increase installation rate of hospital asset management solutions for instrument management.

Request for Analysis of COVID19 Impact on Hospital Asset Management Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1926

Developing Countries Witnessing Government Support for Digitalization in Public Hospitals

Increased government focus on reducing workload of nurses and doctors and rise in focus of hospital administration to ensure patient as well as staff safety fuel the growth of the hospital asset management market in developing regions. In July 2016, the King Hamad University Hospital in Bahrain installed nearly 1,200 asset tags to locate wheelchairs, ultrasound equipment, and IV pumps to improve operational efficiency and response time. Increase in installation of hospital asset management solutions for instrument management is spurring the growth of the global hospital asset management market.

Fragmented Market, with Tier I Players Accounting for Nearly 25.0% Market Share

The report also provides profiles of prominent players operating in the global hospital asset management market. These include Ascom, Awarepoint Corporation, CenTrak, Ekahau, GE Healthcare, Honeywell International, Inc., Impinj, Inc., Sonitor Technologies, STANLEY Healthcare, and ZIH Corp. The global hospital asset management market is significantly fragmented and tier I companies accounted for nearly 25.0% market share in 2017. Strategic partnerships for research and product development has been a characteristic trend among the major players in the global hospital asset management market.

Purchase Hospital Asset Management Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1926<ype=S

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453 
Website: 
https://www.transparencymarketresearch.com/

 

Wearable Injectors Market : Business Growth, Development Factors, Applications, and Future Prospects

4 min read

A report by Transparency Market Research (TMR) throws light on the key dynamics operating within the global market for wearable injectors. The competitive landscape of the global market for wearable injectors has witnessed the entry of several newbie players over the past decade. This abrupt influx of new vendors can be attributed to the large market gap and lucrative growth opportunities floating in the global wearable injectors market. In order to counter the entry of new players, the established players in the global wearable injectors market have launched several schemes and strategies to attract the consumers.

Mergers and acquisitions are projected to be a gold mine for the established market players who can expand their geographical reach by acquiring smaller players. Furthermore, non-price competition is also anticipated to be a key strategy of the larger market players over the forthcoming years. Hence, it is safe to prognosticate that the market vendors within the global wearable injectors market would tread along a path of economic stability over the forthcoming years.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41969

The global market for wearable injectors is projected to expand at a stellar CAGR of 13.95 over the period between 2018 and 2026. The total market value stood at US$ 2,920.2 Mn in 2017 and is expected to reach an astral value of US$ 9,038.1 Mn by 2026. Based on geography, the market for wearable injectors in North America is expected to outdo all other regional segments. On the basis of end-use, diabetics are expected to be the largest consumers of these injectors.

High Incidence of Chronic Diseases to Propel Demand

The demand within the global market for wearable injectors has been escalating on account of the rising incidence of severe chronic diseases. Several patients are in dire need for continual administration of drugs in order to maintain their health, thus, necessitating the need for wearable injectors. The injection of insulin in diabetics is carried out through the use of wearable injectors, and this creates lucrative growth opportunities within the global market for wearable injectors. Treatment of diseases such as cancer, arthritis, psoriasis, and Crohn;s diseases also involves the use of wearable injectors.

The inclination of the masses towards easier methods of drug injection has also le to the growth of the global market for wearable injectors. Furthermore, the rising geriatric population that is at a risk of suffering needle stick injuries also propels demand within the global wearable injectors market.

Request for Analysis of COVID19 Impact on Wearable Injectors Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=41969

Use of Traditional Methods to Hamper Growth

Despite several advantages of wearable injectors, several hospitals and healthcare centers still prefer to use traditional methods for the injection of drugs or hormonal liquids. This has emerged as a huge roadblock for the growth of the global market for wearable injectors. Furthermore, the lack of skilled professionals who can inform and instruct the patients about the usage of wearable injectors also hampers the growth of the global market. However, the nascent developments in the healthcare industry and sophistication of medical procedures are expected to propel demand within the global market for wearable injectors.

The review is based on TMR’s report titled “Wearable Injectors Market (Type - On-body Wearable Injectors, Off-body Wearable Injectors; Application - Oncology, Diabetes, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases; End use Industry - Hospitals, Clinics, Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026”.

Purchase Wearable Injectors Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=41969<ype=S

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Antiseptic and Disinfectant Market is Set to Grow According to Latest Research

7 min read

The global antiseptic and disinfectant market was valued at US$ 6.3 Bn in 2017. It is projected to expand at a compound annual growth rate (CAGR) of 6.2% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled “Antiseptic and Disinfectant Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. The report suggests that rising awareness regarding home cleanliness and the need for disinfection and rising concern regarding healthcare-acquired infections is expected to boost the antiseptic and disinfectant market in the near future.

North America and Europe are projected to dominate the global market owing to increase in demand for efficient and effective management of antiseptic and disinfectant and the high rate of adoption of antiseptic and disinfectant for treatment planning by doctors as well as patients. The market in Asia Pacific is projected to witness expansion at a significant growth rate during the forecast period. Expansion of the market in Asia Pacific is attributed to the large base of private clinics and hospitals, rising geriatric population requiring hospital services after surgery, and increasing adoption of antiseptics for wound care therapy. The market for antiseptic and disinfectant in Latin America is likely to expand at a moderate growth rate during the forecast period.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1695

Value Added Features in Antiseptic & Disinfectant to Fuel Global Market

The global antiseptic and disinfectant market is projected to be potentially driven by the value added features offered by various antiseptic and disinfectant manufacturing companies in order to streamline the day-to-day work flow in treating the patients and increase the revenue of the practices. The antiseptic and disinfectant manufacturing companies provide a wide range of features and benefits from patient pain heeling remedies to treatment procedures, which can be utilized by physicians and hospital staff to treat patients. These features help physicians and nurses to streamline the wound care treatment activity required for patients in order to maintain their daily workflow efficiently and effectively. The key players offering the antiseptic and disinfectant are developing value added features such as effective surgical units with disinfectant sprayer, molecular modeling of proteins and enzymes, thereby reducing the overall chances of infection and thus, improving the overall effectiveness and efficiency of medical or surgery practices. Companies are focusing on the development of combined therapy facilities in their systems in order to effectively integrate the therapy or treatment procedure along with the formulation of antiseptics & drugs, and patient education & awareness programs. These value added features save the operational time of physicians and help improve the performance of the healthcare provider.

Hydrogen Peroxide is projected to be Highly Lucrative Deployment Mode

Traditionally, hydrogen peroxide-based antiseptics and disinfectants were commonly utilized in wound therapy and other disinfectant constituents. Hydrogen peroxide products possess a greater activity against gram-positive than gram-negative bacteria. Hydrogen peroxide is widely employed as a biocide for disinfection, sterilization, and antisepsis and is commercially available in a variety of concentrations, ranging from 3% to 90%. Furthermore, these hydrogen peroxide based antiseptics and disinfectants are priced on perpetual license model and are moderately priced. Hydrogen peroxide products enable the user to practice low frequency clinical applications, allow the healing of extreme pain due to infection, and assurance of 90% recovery features by physicians are likely to propel the segment during forecast period. These hydrogen peroxide-based products address specific challenges faced during the treatment procedure due to the presence of catalase or other peroxidases in the organisms, which can increase tolerance in the presence of lower concentrations of hydrogen peroxide. Hydrogen peroxide-based products facilitate results in antisepsis and increase the level of disinfection & sterilization strength along with a combination of other chemicals.

Request for Analysis of COVID19 Impact on Antiseptic and Disinfectant Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1695

Healthcare Providers Dominates the Market and the Commercial Users Segment is estimated to Expand at Second-highest CAGR During the Forecast Period

In terms of end-user, the healthcare providers segment accounted for leading share of the global antiseptic and disinfectant market. It is estimated to gain market share by the end of 2026, expanding at a CAGR more than 6% during the forecast period. Expansion of the life sciences industry, hospitals, and pharmaceutical industry, etc. has led to the prominent share held by the healthcare providers segment in the global antiseptic and disinfectant market. Increasing number of multinational hospital chains and high digitization budgets for sterilization techniques are likely to drive the healthcare providers segment during the forecast period. High prevalence and incidence rates of hospital acquired infection, expansion of the hospitality and hotel industry, public hygiene, etc. are likely to boost the commercial users segment between 2018 and 2026.

Asia Pacific Offers Potential Business Development Opportunity.

North America and Europe accounted for a key share of the global antiseptic and disinfectant market in 2016. These are likely to gain market share by the end of 2026. High adoption of digital platforms for sterilization technique, and government initiatives to promote the minimally invasive surgery techniques have contributed to leading share of these regions in the global antiseptic and disinfectant market. Asia Pacific is projected to be a highly attractive market for antiseptic and disinfectant, and is likely to exhibit a considerably high attractiveness index. The market in Asia Pacific is projected to expand at high CAGR of more than 7% during the forecast period due to a large number of clinics in emerging countries such as India, China, well-established healthcare facilities, and high adoption of digital healthcare technology in countries such as Japan, Australia & New Zealand, Malaysia, and Singapore. The market in Latin America is anticipated to expand at a moderate growth rate during the forecast period.

Purchase Antiseptic and Disinfectant Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1695<ype=S

Key Trend of R&D to Increase Geographic Presence Observed among Leading Players

The report also provide profiles of leading players operating in the global antiseptic and disinfectant market. 3M Company, Novartis Ag, Johnson & Johnson, STERIS plc, Getinge Group, and Cardinal Health are some of the leading players operating in the global antiseptic and disinfectant market and account for a significant market share. Companies operating in the antiseptic and disinfectant industry are focusing on increasing their geographic presence by means of strategic acquisition and collaboration with leading players in respective domains and geography. According to Thornton & Ross, it has merged with Genus Pharmaceuticals, which is expected to increase the company's OTC brand business in the near future. Other prominent players operating in the global antiseptic and disinfectant include Becton, Dickinson And Company, Whiteley Corporation, and Kimberly-Clark.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

Erectile Dysfunction Drugs Market is Booming Worldwide According to New Research Report

4 min read

The consequences of lifestyle diseases are aplenty. One condition like obesity, hypertension, or diabetes which are also result of stress, can be dangerous to the entire body. One among the several consequences of these conditions is erectile dysfunction. This has created opportunities for growth for players in the global erectile dysfunction drugs market. Transparency Market Research has recently published a report on the global erectile dysfunction drugs market that discusses about the opportunities that lie in store for business between 2018 and 2026. The report points out that the global erectile dysfunction drugs market is expected to grow at a stable pace of 3.2% CAGR during the forecast period. 

While the overall growth rate looks stable, the report points out that the business will remain competent and opportunities to explore may keep emerging during the forecast period. Also, companies will have to remain keen understand if there can be new drugs that will make way for better business avenues in the near future. The popular brands in the global erectile dysfunction drugs market are Pfizer, Dong-AST Co.Ltd., Eli Lilly Company, Bayer AG, and Vivus Inc. 

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1550

Lifestyle Habits that Support Demand

The change in lifestyle in the last two decades has been massive. The change emerges out of growing economic prowess of the people especially in developed and developing nations that allows them to adopt lifestyle habits that, when consumed in excess, can become trouble to the health. Most of these lifestyle habits like alcohol consumption, smoking, consumption of mint and related products, and marijuana etc. are for relaxation. But, most of them also are prone to becoming addiction. And, several scientific studies have proved the impact of addiction and one of them is erectile dysfunction. 

The growing consumption of alcohol; tobacco and other products has had an impact on the number of erectile dysfunction cases. As a result, the companies in the global erectile dysfunction drugs market have gained from this trend. In the years to come, the number of these cases will rise gradually and companies will have more potential for business. 

On the other hand, the stress from work where people end up spending long hours at their work place has also had an impact on the reproductive health of men. With challenging targets to achieve, people end up toiling themselves and neglecting their health. The increased stress level has an impact on the hormones of the body. This trend in the corporate culture is a contributing factor to growth in the global erectile dysfunction drugs market. 

Request for Analysis of COVID19 Impact on Erectile Dysfunction Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1550

Swelling Geriatric Population in Some Pockets to Fuel Growth

Some parts of the world like China and Japan are facing a unique crisis. The senior citizen population in these countries is growing at a rapid pace. This is a critical; indicator for the healthcare industry itself as the demand for products all healthcare markets in these regions will be high. As a result, the global erectile dysfunction drugs market is also expected to benefit from this trend. 

Purchase Erectile Dysfunction Drugs Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1550<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

 

Postoperative Pain Therapeutics Market Growth Opportunities, Key Players, and Threads Analysis

8 min read

Transparency Market Research (TMR) has published a new report, titled, 'Postoperative Pain Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027'. According to the postoperative pain therapeutics market report, the global postoperative pain therapeutics market was valued at US$ 11,459.3 Mn in 2018, and is projected to expand at a CAGR of nearly 4.5% from 2019 to 2027. High incidence and severity of postoperative pain, introduction of promising drugs, increase in the number of surgical procedures, and high rate of adoption of pain management in developed as well as pharmerging countries are spurring the growth of the global postoperative pain therapeutics market. North America and Europe are projected to be prominent regions in the global postoperative pain therapeutics market during the forecast period. The postoperative pain therapeutics market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. The growth of the postoperative pain therapeutics market in the region is attributed to the high rate of adoption of pain management, rise in disposable income, and increase in the number of surgical procedures. The postoperative pain therapeutics market in Latin America is likely to grow at a moderate pace during the forecast period. 

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=67271

High Incidence and Severity of Postoperative Pain, Introduction of Promising Drugs, and High Adoption Rate of Pain Management in Developed as well as Pharmerging Countries to Drive the Postoperative Pain Therapeutics Market

·         The global postoperative pain therapeutics market is projected to be driven by the following factors. Surgical procedures are associated with chronic postoperative pain that persists for a long time, usually for three to six months. Phantom pain is one the common postoperative conditions that occurs after limb amputation, thoracotomy, breast surgery, cesarean section, or inguinal hernia repair.

·         A number of studies conducted in countries with highly-developed healthcare systems demonstrated that, postoperative pain is not managed well in nearly one-third to one-half of the patients. Increase in the number of surgical procedures and severity of postoperative pain are anticipated to drive the global postoperative pain therapeutics market during the forecast period. The introduction of various new drugs is also expected to propel the global postoperative pain therapeutics market. New drugs are being developed with wide safety margins and favorable profiles.

·         Advancements in non-opioid alternatives and adjuncts have gained importance for controlling postoperative pain. For instance, intravenous (IV) acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), magnesium, ketamine, dexmedetomidine, and liposomal bupivacaine are some of the drugs that have gained traction in the postoperative pain therapeutics market.

·         Innovative medicines, increase in demand, better access, and improved treatment for pain have led to the dominance of postoperative pain therapeutics in pharmerging and developed markets. 

 

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=67271

Opioids Projected to be a Highly Lucrative Drug Class in the Postoperative Pain Therapeutics Market

·         Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. Opioids can be classified into three major classes: strong agonists (fentanyl, oxymorphone, and morphine), mild-to-moderate agonists (codeine and hydroxycodone), and opioids with mixed receptor reactions (buprenophrine and pentazocine).

·         The opioids segment dominated the postoperative pain therapeutics market in 2018, and the trend is likely to continue during the forecast period. Growth of the segment can be attributed to the usage of opioids as the primary line of treatment for postoperative pain.

·         However, an increase in the incidences of opioid drug abuse due to addiction, and production shortage of opioids, as reported by Pfizer, are projected to hamper the growth of the postoperative pain therapeutics market in the next few years. 

Oral Route of Administration Leads in the Postoperative Pain Therapeutics Market

·         Oral administration is a route of administration, wherein, medications are taken through the mouth. Medications taken through this route are intended to have a systemic effect and reach different body parts through the bloodstream.

·         The postoperative pain therapeutics market report offers detailed segmentation of the global postoperative pain therapeutics market in terms of route of administration. The oral segment is poised to account for a substantial share of the postoperative pain therapeutics market from 2019 to 2027. High share of the segment is attributed to easy intake, and preference of patients of taking medication orally.

·         The oral segment dominated the postoperative pain therapeutics market in 2018, and this trend is projected to continue during the forecast period. Growth of the segment can be attributed to high preference for the oral route of administration, owing to its non-invasiveness, ease of use, and self-administration. 

 

Request for Analysis of COVID19 Impact on Postoperative Pain Therapeutics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=67271

Hospital Pharmacies Segment Prominent in the Postoperative Pain Therapeutics Market

·         In terms of distribution channel, the hospital pharmacies segment accounted for a leading share of the global postoperative pain therapeutics market in 2018. This segment is likely to gain market share in the postoperative pain therapeutics market during the forecast period.

·         The segment is expected to expand at a high CAGR from 2019 to 2027. Hospital pharmacies can be defined as healthcare facilities inside hospital premises that primarily provide medications to hospital patients. These facilities manage the procurement, storage, packaging, preservation, compounding, sterilization, and distribution of medicines in hospitals.

·         Growth of the segment can be attributed to the rise in the number of surgeries being performed. Additionally, increase in the number of accidents leading to complicated surgeries result in postoperative pain.

·         This drives the demand for postoperative analgesics. Moreover, product availability in hospital pharmacies contributes to the growth of the segment. 

Asia Pacific Presents Significant Opportunities in the Postoperative Pain Therapeutics Market

·         North America and Europe accounted for large shares in the global postoperative pain therapeutics market in 2018, and are projected to gain more market share in the global postoperative pain therapeutics market by the end of 2027. The postoperative pain therapeutics markets in these two regions are anticipated to expand significantly in the next few years, due to the increase in inpatient and outpatient surgeries and well-established healthcare infrastructure. Rise in obesity and lack of exercise have contributed to the high prevalence of chronic disorders, which leads to high number of surgeries.

·         An article published by NCBI stated that, acute pain control leads to approximately 70 million surgical procedures in the U.S. each year. The postoperative pain therapeutics market in Asia Pacific is expanding rapidly due to improving healthcare infrastructure, and rise in private and public investment in life science research in countries such as China and India. Robust economic development, high chronic disease burden, and developing healthcare sector are anticipated to boost the postoperative pain therapeutics market in Asia Pacific.

·         China and Japan are expected to be highly attractive markets for postoperative pain therapeutics in the next few years, due to the increase in the incidences of chronic diseases and rise in the geriatric population. Launch of new products and introduction of abuse-deterrent opioid analgesics in Asia Pacific are likely to drive the opioids segment in the region from 2019 to 2027.

·         The phenomenon of population aging in Japan, China, and India has led to an increase in the number of people with chronic pain, cancer pain, and other diseases. This is expected to drive the NSAIDS and opioids segments in the region during the forecast period. 

 

Purchase Postoperative Pain Therapeutics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=67271<ype=S

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. 

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: 
https://www.transparencymarketresearch.com/

Biopsy Devices Market Status and Forecast, by Players, Types and Applications

4 min read

A new Transparency Market Research report states that the global biopsy devices market was valued at US$1.3 bn in 2011 and is predicted to reach US$2.1 bn by 2018. It is poised to expand at a CAGR of 6.60% from 2012 to 2018. The title of the report is “Biopsy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018.”

Browse the full Biopsy Devices Market (Disposable & Reusable Needles, Hot & Cold Forceps, Needle-based Biopsy Guns, VAB, CNB, FNAB Devices, Guidance Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at https://www.transparencymarketresearch.com/biopsy-devices-market.html

 A biopsy is a procedure in which a sample of cells or a piece of tissue is removed from a living subject for laboratory analysis in order to determine the extent or presence of a disease. Biopsies are significant in order to diagnose cancers. In addition, inflammation in organs such as the kidneys and the liver can also be detected by a biopsy. The devices utilized to perform biopsies are known as biopsy devices.

As per the report, factors such as the increasing geriatric population, the rising occurrence of various cancers globally, and the increasing demand for minimally invasive biopsy procedures are propelling the global biopsy devices market. In addition, the increasing awareness among people about diseases and screening procedures for diseases is also augmenting the growth of the market. In addition, the report states that the increasing unmet medical requirements of people in developing nations will emerge as key growth opportunities in the market. On the other hand, the soaring prices of technologically advanced biopsy devices and problems in medical reimbursement are amongst the chief factors inhibiting the growth of the market for biopsy devices.

Request a PDF Brochurehttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=797

In terms of product type, the report segments the biopsy devices market into needle-based biopsy guns, biopsy needles, biopsy guidance systems, biopsy forceps, and others. Needle-based biopsy guns are further segmented into core needle biopsy (CNB) devices, vacuum-assisted biopsy (VAB) devices, and fine needle aspiration biopsy (FNAB) devices. Biopsy needles are further segmented into reusable and disposable biopsy needles. Biopsy forceps are further segmented into hot biopsy forceps and cold (general) biopsy forceps. Biopsy guidance systems are further segmented into robotic systems and manual systems. The segment of others is further segmented into biopsy punches, biopsy curettes, and biopsy brushes.

Amongst the product types, the segment of needle-based biopsy guns is the most swiftly developing segment of the market for biopsy devices and is predicted to exhibit a CAGR of 8.0% in the forecast horizon. This segment is poised to maintain its superiority owing to the increasing demand for disposable devices in place of reusable devices. Amongst the segment of needle-based biopsy guns, vacuum assisted biopsy devices led the market in terms of demand in 2012.

Request for Analysis of COVID19 Impact on Biopsy Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=797

In terms of geography, the market for biopsy devices is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, the region of North America led the market in 2011, however, the region of Asia Pacific will outpace North America by 2018 and is expected to register a robust 10.5% CAGR in the forecast horizon.

Devicor Medical Products, Inc., Hologic, Inc., and CareFusion Corporation are the prominent players operating in the market for biopsy devices, as stated in this study.

Purchase Biopsy Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=797<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:
https://www.transparencymarketresearch.com